
Why This Medtech Player Says Tariffs Will Be 'Immaterial' In 2025
Edwards Lifesciences (EW) stock inched up late Wednesday after the heart-focused medtech player boosted some elements of its 2025 outlook, but only met March-quarter sales expectations. The Irvine, Calif.-based company is known for its transcatheter aortic …